Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
CA 2450898 A1 · Owner: Receptor Biologix, Inc. · Inventors: Michaeli, Dov; Gevas, Philip C.; Grimes, Stephen
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the treatment and/or prevention of cancerous and/or pre-cancerous conditions of the liver, lung and esophagus by actively and/or passively immunizing a patient against the peptide hormone gastrin and/or a gastrin receptor, e.g. the CCK-B/gastrin receptor. The immunizations of the invention may be employed as a monotherapy an adjunctive therapy, or as part , of a combination therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 9, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 9, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 9, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.